To disentangle the issue, an indication could come from the association between type 1 diabetes (characterized by an absolute lack of insulin and high blood sugar) and an increased ALS risk [12,54], which points to the possibility that T2DM’s protective effect on ALS might stem from unknown signaling pathways rather than from the currently proposed mechanisms. This evidence concerns the gene INS and amyotrophic lateral sclerosis.